Chronic Inflammation & CIRS — When the Immune System Won't Stand Down
CIRS affects an estimated 8 in 10 patients with chronic unexplained health complaints — yet most are never diagnosed.
Chronic Inflammatory Response Syndrome (CIRS) is a multi-system illness triggered by exposure to biotoxins — primarily mold (water-damaged buildings), Lyme disease, post-viral illness, and ciguatera. In genetically susceptible individuals (approximately 25% of the population carry the HLA-DR variants that prevent normal biotoxin clearance), a single significant exposure can trigger a self-perpetuating inflammatory cascade that doesn't resolve when the exposure ends.
The result is a condition that standard medicine consistently fails to diagnose — because standard blood panels almost always come back normal. Meanwhile the patient experiences a constellation of symptoms that looks like chronic fatigue, fibromyalgia, depression, cognitive decline, and autoimmune disease simultaneously.
The MARCONS connection is one of the most important and underrepresented aspects of CIRS. MARCONS (Multiple Antibiotic Resistant Coagulase Negative Staph) colonizes the nasal passages in many CIRS patients — and actively destroys α-MSH, the body's primary anti-inflammatory hormone. This creates a vicious cycle: CIRS depletes α-MSH, which allows MARCONS to thrive, which further destroys α-MSH, which deepens the inflammatory cascade.
CIRS is not a diagnosis of exclusion or a psychological condition. It is a specific, measurable immune dysregulation with identifiable biomarkers, a known genetic susceptibility mechanism, and a growing body of evidence-based treatment protocols. The Shoemaker Protocol — developed by Dr. Ritchie Shoemaker — remains the most validated framework for CIRS diagnosis and treatment.
What Drives CIRS?
Four primary triggers — one common downstream mechanism.
The most common CIRS trigger. Mycotoxins from water-damaged buildings are lipid-soluble and cannot be cleared by the liver in HLA-DR susceptible individuals. They recirculate continuously, maintaining the inflammatory trigger indefinitely.
Borrelia and associated co-infections trigger the same HLA-DR-mediated biotoxin retention pathway. Many "chronic Lyme" cases are more accurately understood as CIRS driven by Lyme biotoxins rather than active ongoing infection.
Post-viral syndromes — including Long COVID — increasingly fit the CIRS framework. Many Long COVID patients carry the same HLA-DR susceptibility variants. CIRS-trained practitioners are applying Thymosin Alpha-1 and KPV to Long COVID with meaningful clinical results.
CIRS depletes α-MSH — the body's primary anti-inflammatory hormone. Low α-MSH allows MARCONS bacteria to colonize the nasal passages. MARCONS actively destroys more α-MSH. This self-perpetuating cycle is why CIRS doesn't resolve without targeted intervention.
Peptides for CIRS & Chronic Inflammation
Five peptides addressing different layers of the CIRS cascade — with Thymosin Alpha-1 and KPV as the anchors.
-
★ Anchor — Immune Modulation Thymosin Alpha-1 (Tα1) Thymosin Alpha-1 is the primary immune modulator in the CIRS protocol. It restores appropriate immune regulation — neither suppressing nor over-activating the immune response, but normalizing the dysregulated TGF-β1 driven inflammatory cascade that defines CIRS. It also directly addresses the elevated TGF-β1 that is one of CIRS's most consistent biomarkers. Used in courses alongside KPV for the full immune restoration effect.
-
★ Anchor — α-MSH Restoration KPV (Lys-Pro-Val) KPV is a tripeptide fragment of α-MSH — the anti-inflammatory hormone destroyed by MARCONS in CIRS patients. KPV directly restores the α-MSH signaling pathway, breaking the MARCONS-α-MSH destruction cycle. Critical protocol note: KPV must be run for a minimum of 4 months without cycling off early. The most common practitioner error in CIRS treatment is discontinuing KPV before the α-MSH pathway is fully restored — which allows the cycle to re-establish.
-
Gut & systemic repair BPC-157 CIRS reliably damages gut integrity — and gut permeability is both a consequence and a driver of ongoing systemic inflammation. BPC-157 repairs the gut lining, reduces intestinal inflammation, and addresses the leaky gut component of CIRS that keeps the inflammatory cycle running. Also relevant for the musculoskeletal pain that commonly accompanies CIRS.
-
Systemic tissue repair TB-4 Fragment (Thymosin Beta-4 Fragment) Supports systemic tissue repair and immune modulation. Works synergistically with BPC-157 for comprehensive healing. Raises underactive immune response — relevant to the immune imbalance driving CIRS.
-
Sleep foundation — nearly always indicated Epithalon CIRS patients almost universally experience disrupted restorative sleep. Epithalon restores deep sleep and REM through pineal gland support — which also supports the same α-MSH-related pathway disrupted by CIRS. Additionally addresses the accelerated telomere shortening driven by chronic systemic inflammation.
KPV Minimum Duration: KPV must be run for a minimum of 4 months continuously. Cycling off early — before the α-MSH pathway is restored — allows MARCONS to re-establish and the destruction cycle to resume. This is the single most common protocol error in CIRS treatment. Work with a CIRS-trained practitioner to determine your specific duration based on α-MSH lab restoration.
The Labs That Reveal What Standard Panels Miss
Standard blood work almost always comes back normal in CIRS. These specific markers reveal the condition.
| Biomarker | What It Measures | In CIRS | Why It Matters |
|---|---|---|---|
| TGF-β1 | Master immune regulator | ↑ Elevated | Primary driver of CIRS immune dysregulation. Target for Thymosin Alpha-1. |
| α-MSH | Anti-inflammatory hormone | ↓ Low | Depleted by MARCONS. Restoration via KPV is central to recovery. |
| MMP-9 | Inflammatory tissue enzyme | ↑ Elevated | Breaks down blood-brain barrier. Drives brain fog and physical symptoms. |
| C4a | Complement inflammation marker | ↑ Elevated | Highly elevated in active CIRS. Useful for tracking treatment response. |
| IGF-1 | Growth hormone status | ↓ Low | Commonly suppressed in CIRS. Relevant to fatigue and recovery capacity. |
| VCS Test | Visual Contrast Sensitivity | ↓ Impaired | Free screening tool (survivingmold.com). Abnormal in ~92% of CIRS cases. |
Source removal first. No peptide protocol will produce lasting results while ongoing biotoxin exposure continues. Mold remediation, binder therapy (cholestyramine, activated charcoal), MARCONS clearance, and anti-inflammatory diet are the non-negotiable foundation. Peptide therapy amplifies a good foundation — it doesn't replace it.
This guide is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. CIRS requires diagnosis and management by a qualified, trained physician. Peptide therapy for CIRS is used off-label and should only be undertaken under physician supervision with appropriate lab monitoring. InformedPeptides.com and its authors are not liable for actions taken based on the content of this page.
Brain Fog & Cognitive Decline — An Energy Problem
The brain uses 20% of your body's energy while being only 10% of its mass. When mitochondria underperform, cognition is the first thing to suffer.
Brain fog and cognitive decline are increasingly understood as energy problems — not simply aging. The brain is the most metabolically demanding organ in the body, consuming approximately 20% of total ATP output despite representing only 10% of body weight. When mitochondrial function declines — as it consistently does with age, chronic inflammation, oxidative stress, and poor sleep — the brain is the first organ to feel it.
The result is the constellation of symptoms most people recognize as brain fog: difficulty concentrating, slow processing speed, poor short-term memory, mental fatigue, word-finding problems, and the persistent sense that your thinking is operating through a filter.
The good news is that for the metabolic and mitochondrial form of cognitive decline — which is the most common form in middle-aged adults — meaningful reversal of symptoms is frequently achievable when the protocol addresses the root cause rather than just the symptoms.
Brain fog is not a diagnosis — it's a symptom of mitochondrial underperformance. The therapeutic approach that works is not stimulants or nootropics that push harder on a depleted system. It's restoring the cellular energy infrastructure that makes clear thinking possible in the first place.
What's Actually Driving Brain Fog?
Four primary drivers — each addressable with targeted interventions.
The primary driver in most cases. Mitochondria in neurons become less efficient with age, chronic stress, and oxidative damage — producing less ATP and more reactive oxygen species. The result is a brain that can't generate the energy required for optimal cognition.
Chronic low-level inflammation — driven by poor diet, gut dysbiosis, omega-3 deficiency, and systemic inflammaging — crosses the blood-brain barrier and impairs neuronal function. Omega-3 deficiency is a particularly common and correctable contributor.
NAD+ is essential for neuronal energy production and DNA repair. Its 50% decline between ages 40 and 60 directly impairs the mitochondrial electron transport chain in brain cells — compounding the energy deficit that drives cognitive symptoms.
Deep sleep is when the brain clears metabolic waste via the glymphatic system and consolidates memory. Declining melatonin and growth hormone output with age disrupts this process — allowing neurotoxic proteins to accumulate and impairing memory consolidation.
The Cognitive Recovery Stack
Five compounds addressing the root causes of brain fog from different angles — with Methylene Blue as the anchor.
-
★ Anchor Compound — Not a peptide Methylene Blue Methylene Blue directly supports the mitochondrial electron transport chain — acting as an electron shuttle that bypasses dysfunctional complexes and restores ATP production. It produces measurable improvements in focus, processing speed, and cognitive clarity. At therapeutic doses it turns urine blue-green — expected and harmless. Critical warning: Methylene Blue has mild MAO inhibitor properties. It must not be combined with serotonergic medications (SSRIs, SNRIs, tramadol) without physician oversight due to serotonin syndrome risk.
-
Mitochondria-targeted peptide — injectable or nasal spray SS-31 (Elamipretide) A mitochondria-targeted peptide that concentrates at the inner mitochondrial membrane — reducing oxidative stress at the site of ATP production and improving mitochondrial efficiency. Available as subcutaneous injection or nasal spray. The nasal spray format provides direct CNS delivery, bypassing the blood-brain barrier for faster neurological effect.
-
Anxiolytic neuropeptide Selank (Selank) A synthetic analog of tuftsin with anxiolytic and nootropic properties. Reduces cognitive anxiety — the mental static that compounds brain fog — while supporting BDNF expression and neuroplasticity. Particularly effective for the brain fog presentation that includes anxiety, overwhelm, and difficulty filtering irrelevant information.
-
Cognitive enhancer CAX (Cortexin) A polypeptide nootropic derived from cortical brain tissue. Supports neuronal metabolism, reduces excitotoxicity, and has demonstrated neuroprotective effects in clinical settings. Works synergistically with Selank — Selank reduces anxiety-driven cognitive impairment while CAX supports the underlying neuronal metabolism.
-
Sleep foundation — always indicated Epithalon Deep sleep is when the brain clears neurotoxic waste via the glymphatic system. Without restorative sleep, no cognitive protocol works optimally. Epithalon restores deep sleep architecture through pineal gland support — making it the foundation on which all other cognitive interventions build.
Methylene Blue + Serotonergic Medications: Combining Methylene Blue with SSRIs, SNRIs, tramadol, or certain migraine medications can cause serotonin syndrome — a potentially serious condition. This combination requires physician oversight and is generally avoided. Always disclose all medications to your provider before starting any Methylene Blue protocol.
The Omega Index — Test Before You Treat
94% of Americans are omega-3 deficient. Neuroinflammation from omega-3 deficiency is one of the most correctable contributors to brain fog.
Before starting any cognitive peptide protocol, the Omega Index is the single most important test to run. The Omega Index measures the percentage of EPA and DHA omega-3 fatty acids in red blood cell membranes — a more accurate reflection of long-term omega-3 status than blood plasma levels.
Target range for cognitive health: 8–12%. Most people test between 4–5%. Correcting omega-3 deficiency with high-quality triglyceride-form fish oil typically takes 3–6 months at therapeutic doses — but the neuroinflammation reduction it produces creates a dramatically better environment for every other cognitive intervention to work in.
OmegaQuant (omegaquant.com) offers an at-home finger-prick test that is the gold standard for consumer omega-3 testing. Results in 2–3 weeks. Order before starting your cognitive protocol and retest at 3 months to confirm correction.
Nasal Spray Delivery — The CNS Shortcut
SS-31 and Selank are both available as nasal spray formulations — delivering compounds directly to the CNS, bypassing the blood-brain barrier.
The blood-brain barrier (BBB) is a selective filter that prevents most compounds from entering the brain from circulation. Nasal spray delivery bypasses this barrier entirely — compounds absorbed through the olfactory epithelium travel directly along olfactory nerves into the CNS, achieving higher brain concentrations faster than systemic injection.
Delivers the mitochondria-targeted peptide directly to neuronal tissue. Particularly useful for acute cognitive performance needs — many practitioners use nasal spray pre-task for rapid focus enhancement. Injectable SubQ remains preferable for ongoing systemic mitochondrial support.
The most common delivery format for Selank. Produces rapid anxiolytic and nootropic effects within 15–30 minutes. Available as standard or nano-spray formulation — nano-spray provides enhanced mucosal absorption and faster onset.
The Cognitive Stack — How It All Fits Together
Each compound in the stack addresses a different layer of the cognitive decline cascade.
Methylene Blue + SS-31 restore mitochondrial ATP production. This is the non-negotiable foundation. Without adequate cellular energy, no other cognitive intervention performs optimally.
Omega-3 correction (Omega Index guided) reduces neuroinflammation. BPC-157 addresses systemic inflammaging that crosses the blood-brain barrier. Combined, these reduce the inflammatory burden that impairs neuronal function.
Selank reduces cognitive anxiety and supports neuroplasticity. CAX supports neuronal metabolism and provides neuroprotection. Together they address the functional cognitive impairment once the energy and inflammation foundation is in place.
Epithalon restores deep sleep architecture — the glymphatic clearance window that removes neurotoxic waste and consolidates memory. Without this layer, cognitive gains from the other compounds are limited by insufficient overnight repair.
Anti-inflammatory diet, corrected omega-3 status, stress and autonomic nervous system regulation, and quality sleep are non-negotiable foundations. Peptide therapy amplifies a good foundation — it doesn't replace it. Labs to run before starting: Omega Index, hsCRP (inflammation), NAD+ levels, IGF-1 (growth hormone status).
Frequently Asked Questions
Brain fog and ADHD share significant symptom overlap — poor focus, distractibility, cognitive fatigue — but have different primary drivers. True ADHD involves dysregulation of dopamine and norepinephrine in specific attention circuits, often with a developmental component. Brain fog is typically more metabolic and mitochondrial in origin. In practice, many people have elements of both — and the mitochondrial support protocol (Methylene Blue + SS-31) is relevant to both, since mitochondrial dysfunction is increasingly recognized as a significant contributor to ADHD-type presentations.
For the metabolic and mitochondrial form of cognitive decline — which is the most common form in middle-aged adults — meaningful reversal of symptoms is frequently achievable, particularly when the protocol is started before irreversible neuronal loss has occurred. The earlier in the cognitive decline trajectory the intervention begins, the greater the potential for meaningful improvement.
Yes — it turns urine blue-green at therapeutic doses. This is expected, harmless, and temporary. It's a reliable indicator that you've reached a therapeutic dose level.
This is a critical question — particularly for Methylene Blue, which has mild MAO inhibitor properties. Combining Methylene Blue with serotonergic medications (SSRIs, SNRIs, tramadol, certain migraine medications) can potentially cause serotonin syndrome. This combination requires physician oversight and is generally avoided. Selank, CAX, SS-31, and Epithalon have lower interaction risk, but any change to a regimen involving psychiatric medications requires physician review before adding any new compound.
This guide is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Methylene Blue and peptide therapy for cognitive decline are used off-label. Always consult a qualified, licensed healthcare provider before beginning any protocol — particularly if taking serotonergic medications. InformedPeptides.com and its authors are not liable for actions taken based on the content of this page.
Tools & Calculators
Practical, free tools for anyone serious about peptide therapy — reconstitution math, dosing calculations, GLP-1 unit conversions, and stack-level analysis. Built to be used alongside your healthcare provider, not in place of one.
Available Now
Four free tools covering reconstitution math, dosing calculations, GLP-1 unit dosing, and stack-level analysis.
Before You Calculate
Our peptide profile pages cover the research, mechanisms, dosing ranges, and stacking strategies behind each peptide — so you know what the calculator is calculating.
Browse Peptide Profiles →What Is NAD+?
The coenzyme that powers every cell in your body — and declines dramatically with age.
NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme found in every living cell. It's not a peptide in the traditional sense — it's a molecule your body produces and requires for hundreds of enzymatic reactions, including the ones that generate cellular energy, repair DNA damage, and regulate the proteins that control aging.
The problem is straightforward: NAD+ levels decline approximately 50% between the ages of 40 and 60. That decline isn't a minor inconvenience — it's one of the most consistent and well-documented biochemical changes in human aging, and it sits upstream of mitochondrial dysfunction, cognitive decline, metabolic slowdown, and impaired DNA repair.
Restoring NAD+ levels has become one of the most actively researched interventions in longevity medicine — with researchers including David Sinclair at Harvard identifying NAD+ restoration as a central pillar of any serious anti-aging protocol.
NAD+ doesn't work through a single mechanism — it's a foundational molecule that enables dozens of other biological processes. Restoring it doesn't just fix one thing; it improves the cellular environment across the board. This is why NAD+ is considered the most important molecule in longevity medicine by many researchers.
How Does NAD+ Work?
Four core mechanisms explain why NAD+ restoration has such broad and profound effects on aging.
NAD+ is the primary electron carrier in the mitochondrial electron transport chain — the process that converts food into ATP (cellular energy). Without adequate NAD+, mitochondria become inefficient, energy production drops, and cellular function across every tissue type declines.
Sirtuins are a family of 7 proteins that regulate aging, stress response, inflammation, and cellular repair. They are entirely NAD+-dependent — they cannot function without it. Declining NAD+ means declining sirtuin activity, which means accelerated aging across multiple biological pathways simultaneously.
PARP enzymes are the primary responders to DNA damage — they detect breaks and coordinate repair. PARP enzymes consume NAD+ as fuel for this process. As DNA damage accumulates with age, PARP activity increases, depleting NAD+ faster and creating a vicious cycle of declining repair capacity and accelerating damage.
NAD+ levels fluctuate with the circadian cycle — rising during the day to fuel activity and dropping at night to signal repair. The CLOCK genes that govern circadian rhythm are directly regulated by NAD+-dependent sirtuins. Disrupted NAD+ metabolism disrupts circadian timing, impairing sleep quality and the repair processes that depend on it.
What Is NAD+ Used For?
From energy restoration to cognitive performance — NAD+ has the broadest application profile of any longevity compound.
- Energy & Fatigue RecoveryThe most immediately noticeable effect for most people. Restoring NAD+ levels improves mitochondrial efficiency — resulting in more consistent energy, reduced afternoon fatigue, and better physical endurance. Effects are often noticeable within the first IV infusion.
- Cognitive Performance & Brain FogNAD+ is critical for neuronal energy production and neuroprotection. Declining NAD+ contributes directly to brain fog, cognitive slowing, and the memory changes associated with aging. Restoration consistently improves mental clarity, focus, and processing speed.
- DNA Repair & Genomic StabilityVia PARP enzyme support, NAD+ restoration improves the body's capacity to repair DNA damage — reducing the accumulation of mutations that drive cancer risk and cellular senescence.
- Metabolic Health & Body CompositionNAD+ supports insulin sensitivity, fat metabolism, and mitochondrial biogenesis — the process of creating new mitochondria. Relevant for anyone experiencing age-related metabolic slowdown, weight gain, or declining muscle mass.
- Addiction & Withdrawal SupportIV NAD+ has been used clinically in addiction medicine — particularly for alcohol and opioid withdrawal — where rapid NAD+ repletion appears to reduce withdrawal severity and craving intensity. One of the more established clinical applications.
- Longevity & Biological Age ReductionVia sirtuin activation, PARP support, and circadian regulation, NAD+ restoration addresses aging at a systems level. It is consistently identified as one of the highest-leverage interventions in longevity medicine.
How to Use NAD+
Three delivery methods — each with distinct use cases, bioavailability profiles, and practical considerations.
IV → SubQ → Oral. A loading series of 3–5 IV infusions to rapidly replete NAD+ levels, followed by subcutaneous NMN injections for ongoing maintenance, with oral NMN or NR on days between injections. This gives you the speed of IV, the bioavailability advantage of subQ, and the cost efficiency of oral as a daily base layer.
NAD+ in a Longevity Stack
NAD+ is the metabolic foundation that makes every other longevity intervention work better.
- +NAD+ + Epithalon — The most synergistic longevity pairing. Epithalon restores circadian rhythm and deep sleep — the conditions under which NAD+ synthesis is naturally upregulated. NAD+ supports the mitochondrial energy production that makes cellular repair during deep sleep possible. Together they address aging from two complementary directions: the cellular clock (telomeres) and cellular fuel (NAD+).
- +NAD+ + GHK-Cu — GHK-Cu's gene regulation includes antioxidant and inflammation-controlling genes that reduce the oxidative stress that depletes NAD+ via PARP activation. By reducing oxidative burden, GHK-Cu helps preserve NAD+ for energy production rather than constant damage repair.
- +NAD+ + BPC-157 — BPC-157 reduces systemic inflammation — one of the primary drivers of PARP over-activation and NAD+ depletion. Lower inflammatory burden means less NAD+ consumed by damage repair and more available for energy production and sirtuin activity.
- +NAD+ + Resveratrol / Quercetin — Resveratrol and quercetin are SIRT1 activators that work synergistically with NAD+ to enhance sirtuin activity. NAD+ provides the substrate; resveratrol amplifies the signal. A well-established pairing in the longevity research literature.
What to Look for When Sourcing NAD+ Precursors
Quality varies enormously between suppliers. These are the markers that separate research-grade product from underdosed supplements.
InformedPeptides may earn a commission on purchases made through affiliate links on this page. This never influences our editorial content or recommendations. We only recommend sources we have independently evaluated.
This page is for educational purposes only and does not constitute medical advice. NAD+ precursors and injectables should be discussed with a qualified healthcare provider. InformedPeptides does not prescribe, diagnose, or treat any medical condition. Always consult a qualified healthcare professional before beginning any protocol.
What Is Epithalon?
The most studied anti-aging peptide for telomere maintenance — backed by over 40 years of Russian clinical research.
Epithalon (also spelled Epitalon) is a synthetic tetrapeptide — just four amino acids: Alanine-Glutamic acid-Aspartic acid-Glycine (Ala-Glu-Asp-Gly). It was developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, where it has been the subject of continuous clinical research since the 1980s.
Epithalon is derived from Epithalamin — a natural peptide extract from the pineal gland. The pineal gland is the body's master regulator of circadian rhythm and the primary source of melatonin. As we age, pineal function declines — disrupting sleep architecture, reducing melatonin output, and impairing the hormonal signaling that coordinates cellular repair during deep sleep.
What distinguishes Epithalon from virtually every other anti-aging peptide is its direct effect on telomeres — the protective caps on chromosomes that function as the biological clock of aging. Epithalon is the only peptide with published human data demonstrating telomere elongation.
Epithalon is the only peptide with published human clinical data demonstrating actual telomere elongation — not just preservation. This places it in a category of its own among anti-aging compounds.
How Does Epithalon Work?
Four distinct mechanisms explain Epithalon's position as the anchor peptide in any serious longevity protocol.
Epithalon activates telomerase — the enzyme responsible for maintaining and elongating telomeres. In most adult somatic cells, telomerase is inactive, causing telomeres to shorten with each cell division. Epithalon reactivates this enzyme, slowing and in some cases reversing telomere shortening.
Epithalon restores the peptide signaling environment of the pineal gland — increasing melatonin output, normalizing circadian rhythm, and restoring the deep sleep architecture that declines with age. This mechanism alone has cascading effects on hormone production, cellular repair, and immune function.
Epithalon upregulates the expression of antioxidant enzymes — particularly superoxide dismutase (SOD) and glutathione peroxidase. These are the body's primary defenses against oxidative stress, one of the key drivers of telomere shortening and cellular aging.
Through pineal restoration, Epithalon normalizes the pulsatile release of growth hormone during deep sleep — the primary window for tissue repair, muscle maintenance, and metabolic regulation. This effect is particularly significant for adults over 40 experiencing age-related GH decline.
What Is Epithalon Used For?
From cellular longevity to sleep restoration — Epithalon addresses aging at its most fundamental level.
- Telomere Maintenance & LongevityThe primary application. Epithalon is the only peptide with published human data showing telomere elongation — making it the anchor compound in any serious longevity protocol. Used in courses of 10–20 days, 1–2 times per year.
- Deep Sleep RestorationOne of the most immediately noticeable effects. Users consistently report significantly improved sleep quality — particularly deeper, more restorative sleep — within the first course. This is the pineal restoration mechanism in action.
- Immune System RegulationEpithalon has demonstrated immunomodulatory effects in both animal and human studies — restoring immune function that declines with age and reducing markers of chronic inflammation.
- Cancer Risk ReductionLong-term Epithalon studies — some spanning 20+ years — have shown significant reductions in cancer incidence and overall mortality in treated populations. This is among the most striking findings in the entire peptide research literature.
- Perimenopause & Hormonal SupportEpithalon has shown particular benefit for women in perimenopause — normalizing hormonal cycling, improving sleep disruption, and reducing the severity of menopausal symptoms through its effect on the pineal-hypothalamic-pituitary axis.
- Retinal ProtectionOne of the more surprising research findings — Epithalon has demonstrated protective effects on retinal function in aging populations, potentially relevant to age-related macular degeneration risk reduction.
What Does the Research Say?
Epithalon has the most extensive human clinical research history of any peptide in the longevity space.
The Epithalon research base is unusual in the peptide space for two reasons: its depth and its duration. Professor Khavinson's team at the St. Petersburg Institute has conducted continuous research on Epithalon since the 1980s — including studies that have followed patients for over 20 years.
Key findings from the human clinical data include:
- Telomere ElongationPublished human data showing measurable telomere elongation in treated subjects — a finding that has not been replicated by any other peptide compound.
- Mortality ReductionLong-term studies showed approximately 33% reduction in overall mortality in Epithalon-treated populations compared to controls — a remarkable finding for any intervention.
- Cancer IncidenceSignificant reduction in cancer incidence observed across multiple long-term studies — consistent with the telomere maintenance and antioxidant gene expression mechanisms.
The majority of Epithalon's clinical research was conducted in Russia and published in Russian-language journals — which has historically limited its visibility in Western medical literature. This doesn't diminish the quality of the research; it explains why Epithalon remains less known in Western clinical practice than its evidence base warrants.
Epithalon in a Longevity Stack
Epithalon is consistently recommended as the anchor peptide in any longevity protocol.
- +Epithalon + NAD+ — The most synergistic longevity pairing. Epithalon restores circadian rhythm and sleep — the conditions under which NAD+ synthesis is upregulated. NAD+ supports the mitochondrial energy production that makes cellular repair during deep sleep possible. Together they address aging from two complementary directions: the cellular clock (telomeres) and cellular fuel (NAD+).
- +Epithalon + BPC-157 — A foundational anti-aging stack. BPC-157 addresses inflammaging — the chronic low-level inflammation that accelerates telomere shortening via oxidative stress. By reducing the inflammatory burden, BPC-157 preserves the telomere length that Epithalon works to maintain.
- +Epithalon + CJC-1295 + Ipamorelin — When IGF-1 testing shows growth hormone decline, adding a GH secretagogue stack amplifies the hormonal support that Epithalon initiates via pineal restoration. Particularly relevant for adults over 45 experiencing body composition changes or persistent fatigue.
- +Epithalon + GHK-Cu — The most complete anti-aging skin and longevity stack. Epithalon targets the chromosomal clock; GHK-Cu targets gene regulation, collagen synthesis, and the downstream tissue aging that telomere shortening produces. A complete anti-aging pairing for those prioritizing both longevity and aesthetic outcomes.
Quality Epithalon — What to Look For
Epithalon quality varies significantly between suppliers. These are the markers of a reputable source.
- ✓ Third-party Certificate of Analysis (CoA) available on request
- ✓ Purity ≥98% confirmed by HPLC testing
- ✓ Lyophilized (freeze-dried) powder — not pre-mixed solution
- ✓ Correct amino acid sequence confirmed (Ala-Glu-Asp-Gly)
- ✓ Cold-chain shipping with temperature indicator included
- ✗ No CoA available or supplier refuses to provide one
- ✗ Pre-reconstituted liquid Epithalon (highly unstable)
- ✗ Unusually low price — purity almost certainly compromised
- ✗ Shipped without cold-chain packaging in warm months
- ✗ No contact information or traceable company behind the product
IGF-1 (growth hormone status), hsCRP (inflammatory burden), and telomere length testing give you a meaningful baseline to track against. Retest telomere length after 12 months of consistent Epithalon use — this is the clearest objective marker of the peptide's effect on your specific biology.
This page is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified, licensed healthcare professional before beginning any peptide protocol. InformedPeptides.com and its authors are not liable for actions taken based on the content of this page.
What Is GHK-Cu?
A naturally occurring copper peptide that your body produces — and that declines significantly as you age.
GHK-Cu (Glycine-Histidine-Lysine-Copper) is a naturally occurring tripeptide found in human plasma, saliva, and urine. Unlike synthetic peptides engineered from scratch, GHK-Cu is something your body already makes — it just makes progressively less of it as you age.
At age 20, plasma GHK-Cu levels are approximately 200 ng/mL. By age 60, that figure has dropped to around 80 ng/mL — a decline of roughly 60%. That decline correlates with some of the most visible and measurable signs of aging: reduced skin thickness, slower wound healing, decreased collagen production, and impaired tissue repair.
What makes GHK-Cu particularly compelling in the anti-aging space is its gene regulation capability. Research has shown it can modulate the expression of over 4,000 human genes — including genes that control inflammation, tissue repair, antioxidant defense, and collagen synthesis. This isn't a peptide that does one thing. It's a biological signal that influences aging at a systems level.
GHK-Cu doesn't just stimulate collagen — it modulates the entire remodeling process, activating the genes that build new collagen while simultaneously activating the genes that clear damaged collagen. It's a complete tissue renewal signal, not just a stimulant.
How Does GHK-Cu Work?
Four distinct biological mechanisms explain GHK-Cu's broad anti-aging effects.
The copper ion in GHK-Cu isn't decorative — it's essential. Copper is a required cofactor for lysyl oxidase, the enzyme that cross-links collagen and elastin fibers into functional tissue. GHK acts as a transport vehicle, delivering bioavailable copper precisely where tissue repair is occurring.
GHK-Cu simultaneously stimulates collagen synthesis and activates matrix metalloproteinases (MMPs) that clear damaged collagen. The result is net new functional collagen — not just more of the degraded collagen already present in aged tissue.
GHK-Cu's most significant mechanism is its ability to modulate gene expression at scale. It activates genes associated with tissue repair, antioxidant defense, and anti-inflammation, while downregulating genes associated with inflammation, cancer progression, and cellular aging.
Like BPC-157, GHK-Cu stimulates angiogenesis — the formation of new blood vessels. In wound healing contexts, this accelerates the delivery of repair materials to damaged tissue and is one reason GHK-Cu has been studied extensively in post-surgical recovery.
What Is GHK-Cu Used For?
From skin to scalp to systemic anti-aging — GHK-Cu has one of the broadest application profiles of any peptide.
- Skin Anti-Aging & Collagen RestorationThe most well-documented application. Topical GHK-Cu has been shown to increase skin thickness, improve elasticity, reduce fine lines, and restore the collagen density that declines with age. Multiple peer-reviewed studies support its use as a topical anti-aging agent.
- Wound Healing & Scar ReductionGHK-Cu accelerates wound closure and improves scar quality — producing softer, less visible scars with better collagen architecture than untreated wounds. Used clinically in post-surgical contexts and studied for burn recovery.
- Hair Loss & Scalp HealthApplied topically to the scalp, GHK-Cu has demonstrated the ability to enlarge hair follicles, stimulate hair growth, and reduce follicle miniaturization — the process that causes pattern baldness. Comparable results to minoxidil in some studies, without the side effects.
- Systemic Anti-Aging & LongevityVia its gene regulation mechanisms, GHK-Cu addresses aging at a systems level — reducing inflammaging, supporting antioxidant gene expression, and modulating the genes associated with biological aging and cellular senescence.
- Lung & Tissue RepairGHK-Cu has shown significant effects in lung tissue repair models — particularly relevant for age-related decline in lung function and recovery from respiratory damage. One of the less-discussed but well-researched application areas.
Free Download
60% Gone By Age 60. Here's How to Get It Back.
Get the free GHK-Cu guide — delivery methods, copper monitoring, and a doctor conversation script, instantly delivered.
What Does the Research Say?
GHK-Cu has a longer and more diverse research history than almost any other peptide in the longevity space.
GHK-Cu was first isolated in 1973 by Dr. Loren Pickart — giving it approximately 50 years of research history. That longevity of study means the evidence base is broader and more established than most peptides discussed in wellness contexts.
Human skin studies have consistently demonstrated improvements in skin thickness, elasticity, and collagen density with topical GHK-Cu application. These aren't animal studies extrapolated to humans — they're direct human trial data on the target tissue.
Gene regulation research led by Dr. Pickart identified GHK-Cu's ability to modulate over 4,000 human genes — work that reframed GHK-Cu from a simple wound-healing compound to a broad biological age-reset signal. This research is among the most significant in the peptide anti-aging space.
GHK-Cu's topical applications have the strongest human evidence base. Injectable and systemic protocols are supported primarily by mechanistic science and animal data — with growing real-world human use through functional medicine practitioners providing an emerging safety and efficacy picture.
GHK-Cu in a Longevity Stack
GHK-Cu fills a unique role in a longevity stack — addressing both aesthetic aging and the underlying gene regulation that drives it.
- +GHK-Cu + Epithalon — The most complete anti-aging skin and longevity stack. Epithalon maintains telomere length — the chromosomal clock that determines cellular lifespan. GHK-Cu maintains the collagen and gene regulation that determines how well those cells function. These two peptides address aging from the inside out (Epithalon, telomeres) and the outside in (GHK-Cu, structural tissue and gene expression).
- +GHK-Cu + BPC-157 — A powerful tissue repair and anti-inflammaging combination. BPC-157 drives angiogenesis and tissue regeneration at injury sites; GHK-Cu amplifies the collagen deposition and wound remodeling phase that follows. Together they cover the full repair cycle.
- +GHK-Cu + NAD+ — GHK-Cu's gene regulation includes antioxidant and inflammation-controlling genes that help preserve NAD+ for energy production. These two compounds operate on complementary longevity pathways — GHK-Cu at the gene regulation and structural level, NAD+ at the mitochondrial energy and DNA repair level.
- +GHK-Cu + Microneedling — Microneedling creates micro-channels that dramatically increase topical GHK-Cu penetration to the deeper dermal layers where fibroblasts reside — producing significantly greater collagen stimulation than topical application alone.
Quality GHK-Cu — What to Look For
GHK-Cu is widely available in topical and injectable forms — but quality varies significantly.
- ✓ Certificate of Analysis (CoA) — purity ≥98% by HPLC
- ✓ Correct copper chelation confirmed — GHK-Cu not just GHK
- ✓ Clearly stated concentration
- ✓ Lyophilized powder for injectable
- ✓ Stable pH-balanced formulation for topicals (pH 6–7)
- ✗ Products labeled "GHK" without copper
- ✗ Topicals with very low concentration (<0.5%)
- ✗ No CoA available or supplier refuses to provide one
- ✗ Injectable supplied as pre-mixed liquid
- ✗ Unusually low price
No specific lab work is required to start topical protocols. For injectable or extended oral protocols, consider baseline serum copper and zinc levels before starting — and recheck at 8 weeks. The copper-to-zinc ratio is the most informative marker.
Quick Reference
This page is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified, licensed healthcare professional before beginning any peptide protocol. InformedPeptides.com and its authors are not liable for actions taken based on the content of this page.
Search
Tags
anti-aging anti aging anxiety BDNF body-composition bpc-157 cellular-energy cirs cjc-1295 cognitive-performance collagen energy epithalon fat-loss ghk-cu ghrh growth-hormone gut health healing igf-1 immune-modulation inflammation ipamorelin KPV leaky gut longevity metabolic-health mitochondria mold-illness mood muscle nad nad-plus neuroprotection nmn nootropic peptide-calculator recovery Semax sermorelin sleep tb-500 tendon weight-loss wound-healing





